BCI Marketplace
Transcranial Magnetic Stimulation trials

Efficacy of Repeated Transcranial Magnetic Stimulation Combined With a Live Probiotic Tablet (Combined Bifidobacterium, Lactobacillus, Enterococcus and Bacillus Cereus Tablets, Live) in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

RecruitingNCT06960369Phase: PHASE1Started 2024-12-01

Summary

To evaluate the overall efficacy of repeated Transcranial Magnetic Stimulation(rTMS) combined with a Live Probiotic tablet (Combined Bifidobacterium, Lactobacillus, Enterococcus and Bacillus cereus Tablets, Live) in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Methods: Clinical efficacy evaluation of TMS combined with Live Probiotic tablet for chronic diarrhea in IBS patients. The 400 IBS patients who meet the recruitment criteria for the clinical study will be randomized into 100 pat

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
70 Years

Inclusion Criteria: 1. Must meet the diagnostic criteria for Irritable Bowel Syndrome of Rome IV. 2. Age range between 18-70 years. 3. The duration of the disease is more than 6 months. 4. There are no pathologic abnormalities or biochemical changes that could explain the bowel-related symptoms. 5.

Locations

The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →